scholarly article | Q13442814 |
P356 | DOI | 10.1007/BF02029532 |
P953 | full work available at URL | http://link.springer.com/article/10.1007/BF02029532/fulltext.html |
http://link.springer.com/content/pdf/10.1007/BF02029532.pdf | ||
http://link.springer.com/content/pdf/10.1007/BF02029532 | ||
P698 | PubMed publication ID | 6224687 |
P2093 | author name string | H. Meier-Ewert | |
G. Weil | |||
G. Millott | |||
P2860 | cites work | Chlamydial infection of the male urethra | Q33654975 |
In vitro antibacterial activity of AM-715, a new nalidixic acid analog | Q34709856 | ||
Comparative in vitro activity of Mk-0366 and other selected oral antimicrobial agents against Neisseria gonorrhoeae | Q35671269 | ||
Comparative in vitro activity of norfloxacin against urinary tract pathogens | Q57991345 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | microbiology | Q7193 |
Chlamydia trachomatis | Q131065 | ||
P304 | page(s) | 271-272 | |
P577 | publication date | 1983-06-01 | |
P1433 | published in | European journal of clinical microbiology | Q27710821 |
P1476 | title | In vitro activity of norfloxacin againstChlamydia trachomatis | |
P478 | volume | 2 |
Q35568919 | Activities of new quinoline derivatives against genital pathogens |
Q37905259 | Activity of the newer quinolones against Chlamydia trachomatis |
Q37902543 | Antimicrobial chemotherapy of chlamydial infection: where next? |
Q35575297 | Failure of norfloxacin to eradicate Chlamydia trachomatis in nongonococcal urethritis |
Q69548929 | Fluoroquinolone antimicrobial agents |
Q37906392 | In vitro activities of ciprofloxacin, norfloxacin, pipemidic acid, cinoxacin, and nalidixic acid against Chlamydia trachomatis |
Q43441418 | In vitro activity of ciprofloxacin against clinical isolates of Chlamydia trachomatis |
Q39681144 | Norfloxacin: clinical pharmacology and clinical use. |
Q37905501 | The activity of ciprofloxacin and other 4-quinolones againstChlamydia trachomatis andMycoplasmas in vitro |